Abstract

A REVIEW ON GASTRIC CANCER TREATMENT

Chavan Nikita*, Chavan Payal, Anjali Pawar, Shyam S. Rathod

Abstract

Gastric cancer is the second most common cause of cancerrelated death globally and continues to be a significant global health burden. The majority of cases are adenocarcinomas, which are frequently brought on by a confluence of environmental exposures, dietary practices, genetic vulnerability, and Helicobacter pylori infection. In many areas, early-stage stomach cancer is often asymptomatic, leading to a poor prognosis and delayed diagnosis. Higher incidence is found in portions of South America, Eastern Europe, and East Asia, according to epidemiological variables. Chronic H. pylori infection, a high-salt diet, processed and smoked foods, smoking, obesity, and a low fruit and vegetable intake are all significant risk factors. Promising outcomes have been demonstrated by preventative measures such H. pylori eradication, dietary changes, quitting smoking, and routine endoscopic screening in high-risk groups. Depending on the stage of the tumor, treatment options include endoscopic resection, gastrectomy withradiation, chemotherapy, lymphadenectomy, and more recent multimodal techniques. Programs for early detection greatly increase 5-year survival rates. The epidemiology, risk factors, preventative measures, clinical characteristics, and contemporary management techniques for stomach cancer are all presented in this review.

Keywords: Higher incidence is found in portions of South America, Eastern Europe, and East Asia, according to epidemiological variables.